Publication | Closed Access

The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction

Regenerative MedicineTissue EngineeringCardiac MuscleEngineeringMedicineStem Cell ResearchCardiac RegenerationStem-cell TherapyPurified CardiomyocytesCell BiologyBiomedical EngineeringFunctional Tissue EngineeringStem CellsCell TransplantationCardiologyHuman EscsExtracellular MatrixMyocardial Infarction